Skip to main content
Market intelligence
BOLTHealthcare

Bolt Biotherapeutics Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 18, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 18, 2026Grant YonehiroChief Operating OfficerSale13,176$3.32$43,806
Sep 18, 2026Sarah NemecSenior VP, Finance and PAOSale8,351$3.36$28,045
Sep 18, 2026William P. QuinnPresident, CEO and CFOSale18,203$3.34$60,871